Team
Executed by an interdisciplinary, world-class team with deep experience in RNA and structural biology, artificial intelligence, machine learning, genomics, engineering, and physics, we are THE RNA structure company. We value care, boldness, results-focus, teamwork and growth mindset.
Executed by an interdisciplinary, world-class team with deep experience in RNA and structural biology, artificial intelligence, machine learning, genomics, engineering, and physics, we are THE RNA structure company. We value care, boldness, results-focus, teamwork and growth mindset.
Scientific Advisors
Nicholas Meanwell
Drug Hunter and Medicinal Chemist
Former Scientific VP of Small Molecule Drug Discovery at Bristol-Myers Squibb
Advanced 33 clinical candidates over a 40-year career at BMS.
Amanda Garner
RNA Drug Discovery, Chemistry, and Biology
Associate Professor, Medicinal Chemistry, University of Michigan
Works to unlock the druggability of RNA by bridging chemistry and biology.
Gene Yeo
RNA Biology and RNA Therapeutics
Professor of Cellular and Molecular Medicine, UCSD
His research focuses on the importance of RNA processing and the roles that RNA binding proteins play in development and disease.
Ron Dror
Computational Biology and Machine Learning
Professor of Computer Science, Stanford University
Leads a research group that uses molecular simulation and machine learning to elucidate biomolecular structure, dynamics, and function.
Percy Carter
Drug Discovery Leader and Biotech Executive
CSO of Blueprint Medicines and Board Member of HiFiBiO Therapeutics
Previous scientific leadership roles at Fibrogen, Janssen, and BMS.
Our Investors
